Potention of L-carnitine supplementation on changes in ejection fraction and left ventricular dimension in case of dilatative cardiomyopathy in children

• Main Authors: Wahyu Wibowo, -, Mahrus A. Rahman, -, I Ketut Alit Utamayasa, -
• Format: Article PeerReviewed
• Language: English; English; English; English; English
• Published: Foundation for Enviromental Protection and Research 2020
• Subjects: R Medicine (General); RJ Pediatrics
• Online Access: https://repository.unair.ac.id/109014/1/Potention%20of%20L-carnitine%20supplementation%20on%20changes%20in%20ejection%20fraction%20and%20left%20ventricular%20dimension%20in%20case%20of%20dilatative%20cardiomyopathy%20in%20children.pdf; https://repository.unair.ac.id/109014/2/Potention%20of%20L-carnitine%20supplementation%20on%20changes%20in%20ejection%20fraction%20and%20left%20ventricular%20dimension%20in%20case%20of%20dilatative%20cardiomyopathy%20in%20children.pdf; https://repository.unair.ac.id/109014/3/Potency%20of%20L.pdf; https://repository.unair.ac.id/109014/6/Bukti%20Korespondensi%20Potention%20of%20L.pdf; https://repository.unair.ac.id/109014/8/8.pdf; https://repository.unair.ac.id/109014/; http://www.ejobios.org/article/potention-of-l-carnitine-supplementation-on-changes-in-ejection-fraction-and-left-ventricular-7961
• Institution: Universitas Airlangga

Background: Cardiomyopathy is a rare cardiac muscle disease with poor prognosis and high mortality. The main goal of dilated cardiomyopathy therapy is to restore and maximize cardiac function, but to date no medication has met these criteria. The use of oral L-carnitine as a dilated cardiomyopathy t...